Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - SHORT-TERM INVESTMENTS
Short-term Investments REGN - Regeneron Pharmaceuticals, Inc.
6.52 B
LAST VALUE
18.63%
2 YEAR CAGR
32.52%
5 YEAR CAGR
38.47%
10 YEAR CAGR